Tempest Therapeutics Inc (TPST) Insider Trading
- $5,109,561.20
- $966,798.90
- Aug. 12, 2024
- Versant Venture Capital Vi, L.
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 12, 2024 | Major Shareholder | 387,999 | $1.10 | Sell | $426,798.90 | |
| Aug. 8, 2024 | Major Shareholder | 400,000 | $1.35 | Sell | $540,000.00 | |
| July 3, 2024 | CEO | 35,000 | $2.11 | Buy | $73,850.00 | |
| July 2, 2024 | Insider | 4,672 | $2.13 | Buy | $9,951.36 | |
| June 28, 2024 | Insider | 7,500 | $2.16 | Buy | $16,200.00 | |
| April 29, 2022 | Director | 2,118,644 | $2.36 | Buy | $4,999,999.84 | |
| Jan. 7, 2022 | President | 2,000 | $4.78 | Buy | $9,560.00 |
Insiders are both buying and selling Tempest Therapeutics Inc stock.
The insider traders at Tempest Therapeutics Inc are: Versant Venture Capital Vi, L., Justin Trojanowski, Samuel Whiting, Stephen R Brady, Thomas W Dubensky, and Thomas Woiwode
The most active insider trader at Tempest Therapeutics Inc is Versant Venture Capital Vi, L. with 2 trades.
Versant Venture Capital Vi, L. has sold the most Tempest Therapeutics Inc stock with a total value of $1,393,597.80.
Thomas Woiwode has bought the most Tempest Therapeutics Inc stock with a total value of $9,999,999.68.
The most recent insider trade for Tempest Therapeutics Inc was on Aug. 12, 2024.
The single biggest insider buy for Tempest Therapeutics Inc was from Thomas Woiwode with a total value of $4,999,999.84 on April 29, 2022.
The single biggest insider sell for Tempest Therapeutics Inc was from Versant Venture Capital Vi, L. with a total value of $540,000.00 on Aug. 8, 2024.